These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9610339)

  • 1. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Barber L; Gray JL; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):279-89. PubMed ID: 9610339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of the regression of intimal hyperplasia in experimental vein grafts.
    Davies MG; Fulton GJ; Svendsen E; Hagen PO
    Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.
    Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
    Surgery; 1998 Feb; 123(2):218-27. PubMed ID: 9481409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
    J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
    J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
    Davies MG; Fulton GJ; Barber L; Dalen H; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):151-61. PubMed ID: 8760976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
    Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
    J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts.
    Annex BH; Davies MG; Fulton GJ; Huynh TT; Channon KM; Ezekowitz MD; Hagen PO
    J Surg Res; 1998 Dec; 80(2):164-70. PubMed ID: 9878308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locally applied antisense oligonucleotide to proliferating cell nuclear antigen inhibits intimal thickening in experimental vein grafts.
    Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
    Ann Vasc Surg; 1998 Sep; 12(5):412-7. PubMed ID: 9732417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
    Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
    Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine.
    Davies MG; Dalen H; Kim JH; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1995 Jul; 59(1):35-42. PubMed ID: 7630134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor.
    Luo Z; Asahara T; Tsurumi Y; Isner JM; Symes JF
    J Vasc Surg; 1998 Jan; 27(1):167-73. PubMed ID: 9474095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The integrity of experimental vein graft endothelium--implications on the etiology of early graft failure.
    Davies MG; Klyachkin ML; Dalen H; Massey MF; Svendsen E; Hagen PO
    Eur J Vasc Surg; 1993 Mar; 7(2):156-65. PubMed ID: 8462704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of the structural and functional consequences of vein graft intimal hyperplasia with a 21-aminosteroid--U74389G.
    Davies MG; Barber L; Dalen H; Svendsen E; Hagen PO
    Eur J Vasc Surg; 1994 Jul; 8(4):448-56. PubMed ID: 8088396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
    el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
    Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
    Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low molecular weight heparin on intimal hyperplasia in vein grafts.
    Wilson NV; Salisbury JR; Kakkar VV
    Eur J Vasc Surg; 1994 Jan; 8(1):60-4. PubMed ID: 8307218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of perioperative storage solutions on long-term vein graft function and morphology.
    Davies MG; Hagen PO
    Ann Vasc Surg; 1994 Mar; 8(2):150-7. PubMed ID: 8198948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of experimental vein graft intimal hyperplasia by ketanserin.
    Massey MF; Davies MG; Svendsen E; Klyachkin ML; Schwartz LB; Barber L; McCann RL; Hagen PO
    J Surg Res; 1993 Jun; 54(6):530-8. PubMed ID: 8412062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.